bpc 157 tb 500 safety side effects BPC-157 vs TB-500: Complete Comparison (2026) Multifunctionality and Possible Medical Application

And does the science back up the claims

Using unregulated "research chemical" products with unknown purity, incorrect concentrations, and potential contamination (bacterial endotoxins, heavy metals, residual solvents) introduces risks that have nothing to do with the peptide

Med Sci Monit (2022) 28:e935232

There is evidence that BPC 157 prevents and reverses thrombosis formation after abdominal anastomosis and the occlusion of major vessels [27,28,29,30], and that it alleviates the peripheral vascular occlusion disturbances [27,28,29,30,31,32,33,34,35] while rapidly activating alternative bypassing pathways [28,29,30,31,32,33,34]

Pro-Angiogenic Risk : BPC-157's ability to upregulate Vascular Endothelial Growth Factor (VEGF) raises preliminary concerns about potential support for abnormal cell growth